Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.

Journal article

Ragonnet-Cronin M. et al, (2023), Nat Commun, 14

Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6

Journal article

Dijokaite-Guraliuc A. et al, (2022), Cell Discovery, 8

Switching of Receptor Binding Poses between Closely Related Enteroviruses

Journal article

Zhou D. et al, (2022), Viruses, 14, 2625 - 2625

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Journal article

Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Journal article

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

Antibody evasion by the P.1 strain of SARS-CoV-2

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Journal article

Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Journal article

Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Journal article

Huo J. et al, (2021), Nature Structural & Molecular Biology, 28, 326 - 326

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Journal article

Huo J. et al, (2020), Nature Structural & Molecular Biology, 27, 1094 - 1094

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Journal article

Zhou D. et al, (2020), Nature Structural & Molecular Biology, 27, 950 - 958

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Journal article

Huo J. et al, (2020), Cell Host & Microbe, 28, 445 - 454.e6

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Journal article

Huo J. et al, (2020), Cell Host & Microbe, 28, 497 - 497

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Journal article

Huo J. et al, (2020), Nature Structural & Molecular Biology, 27, 846 - 854

Structural insights into the stabilization of active, tetrameric DszC by its C-terminus.

Journal article

Zhang L. et al, (2014), Proteins, 82, 2733 - 2743

Crystallization and preliminary structural analysis of dibenzothiophene monooxygenase (DszC) from Rhodococcus erythropolis.

Journal article

Duan X. et al, (2013), Acta crystallographica. Section F, Structural biology and crystallization communications, 69, 597 - 601